Major histocompatibility complex class II (MHC II) molecules are expressed on the surface of antigen presenting cells and display short bound peptide fragments derived from self and nonself antigens. These peptide-MHC complexes function to maintain immunological tolerance in the case of self antigens and initiate the CD4 + T cell response in the case of foreign proteins. Here we report the application of LC-MS/MS analysis to identify MHC II peptides derived from endogenous proteins expressed in freshly isolated murine splenic DCs. The cell number was enriched in vivo upon treatment with Flt3L-B16 melanoma cells. In a typical experiment, starting with about 5x 10 8 splenic DCs, we were able to reliably identify a repertoire of over 100 MHC II peptides originating from about 55 proteins localized in membrane (23%), intracellular (26%), endo-lysosomal (12%), nuclear (14%) and extracellular (25%) compartments. Using synthetic isotopically labeled peptides corresponding to the sequences of representative bound MHC II peptides, we quantified by LC-MS relative peptide abundance. In a single experiment, 
3 peptides were detected in a wide concentration range spanning from 2.5 fmol/µL to 12 pmol/µL or from approximately 13 copies to 2x10 5 copies per DC. These peptides were found in similar amounts on B cells where we detected about 80 peptides originating from 55 proteins distributed homogenously within the same cellular compartments as in DCs. About 90 different binding motifs predicted by the epitope prediction algorithm were found within the sequences of the identified MHC II peptides. These results set a foundation for future studies to quantitatively investigate the MHC II repertoire on DCs generated under different immunization conditions.
Introduction
Identification of vaccines and immune therapies should benefit from knowledge of antigenic peptide sequences originating from proteins that are presented on MHC I and MHC II molecules on antigen presenting cells. The most specialized antigen presenting cells are dendritic cells (DCs) [1] [2] [3] . They display self antigens for the induction of tolerance 4, 5 and they capture foreign antigens by phagocytosis, pinocytosis and receptor mediated uptake to initiate T cell immunity 6, 7 . However, there are no direct studies of the spectrum of MHC II peptides that are presented by DCs 8, 9 .
B cells like DCs display self peptides and they are specialized to capture antigens via the B cell receptor 10 . Following antigen processing and presentation to T cells, particularly in germinal centers, the B cells expand, undergo isotype switching and develop high affinity and specific antibodies 11, 12 . Peptides presented by MHC II molecules on B cells have been characterized by several groups by LC-MS/MS analysis using between 10 9 and 10 10 cells from established cell lines [13] [14] [15] [16] [17] .
Numerous studies have established that MHC II molecules present peptides generated from endogenous cellular proteins by proteolytic degradation 13, 14, 17 . They vary in length from 8 -30 amino acids and are usually found as nested sets of peptides with a core sequence shared among them [18] [19] [20] [21] . In the past, limited numbers of DCs isolated from normal mouse spleen have restricted their use for proteomic analysis. The number of DCs in various tissues of mice can be expanded in vivo by treatment with Flt3L [22] [23] [24] , which is a regulator of hematopoietic cell development 25 . The receptor, Flt-3 or Flt-2 or CD135, is a marker for committed progenitors of DCs that form in the bone marrow and then continue to respond to Flt3L after migration via the blood into spleen and lymph nodes 25-5 30 . It has been demonstrated that these Flt3L mobilized DCs resemble their counterparts in untreated mice 31 .
We postulated that these Flt3L DCs can be used to identify the repertoire of peptides bound to MHC II molecules on DCs by mass spectrometry. Here we will show that this is indeed feasible. We find that MHC II bound peptides are presented on DCs over a wide range of copies per cell and their abundance is similar in DCs and B cells. In both DCs and B cells they originate from proteins localized quite uniformly among different intracellular compartments. There was a good agreement between the MHC II peptide sequences identified by LC-MS/MS and sequences predicated from the epitope binding algorithm.
Materials and Methods

Mice
Balb/c x C57Bl/6 (C x B6) F1 mice from Harlan Animal Research Laboratory (3565 Paysphere Circle, Chicago, IL 60674 USA) were maintained under specific pathogen-free conditions and used at 6-8 wk of age in accordance with Rockefeller University Animal Care and Use Committee guidelines.
Cell lines, Antibodies, Reagents
Melanoma cells expressing Fms-like tyrosine kinase 3 ligand (Flt3L) were established via retroviral gene transfer 32 and generously provided by L. Santambrogio (Albert Einstein
College of Medicine, New York, NY). B16 Flt3L melanoma cells were cultured with DMEM containing 10% FBS and 5 x 10 6 were injected s.c into the abdomen region of 6 mice. After 15-20 days, all major splenic DC subsets had expanded >10 fold in agreement with previous reports 22, 33 . The anti-MHC class II (N22) hydridoma cells 22, 33 were maintained in DMEM medium with 2 mM L-glutamine, 10% heat-inactivated FBS and 1% penicillin-streptomycin. The N22 monoclonal antibody was affinity-purified from culture supernatants using Protein G Sepharose (Amersham Biosciences). Poly IC (polyinosinic:polycytidylic acid) was from Thermo Scientific (Waltham, MA, USA).
Cell enrichment
Flt3L treated mice were injected in vivo with poly IC (50 µg) for 5 hr prior to harvesting their spleens. Spleens were removed, cut in small fragments, and digested into single cellsuspensions with 400 U/ml collagenase D (Roche Applied Science) for 25 min at 37 0 C.
After inhibition of collagenase with 10 mM EDTA, cells were resuspended in PBS in 2 mM EDTA and 2% FCS. CD11c + DC were enriched by positive selection using anti-
CD11c magnetic beads and MACS columns (Miltenyi Biotec). From a pool of 12-17
mice we could typically obtain from 5x10 8 
Purification of peptides bound to the MHC II molecules
MHC II peptide complexes were boiled at 70 o C for 10 min. MHC II peptides were separated from the denatured protein subunits of the HLA molecules and the contaminating antibody by ultrafiltration through a 10 kD cutoff membrane filter (Sartorius Stedim, Aubagne, France) and centrifugation at 3000 g. The filters were washed three times with 2 ml water to remove contaminants interfering with the mass 8 spectrometry. Recovered peptide mixtures (5-6 ml) were concentrated and desalted with C-18 cartridge (Waters, Medford, MA). The C-18 cartridge was first washed three times with 50% acetonitrile (1.5 ml), equilibrated with 0.1% trifluoracetic acid (TFA) in water, and then loaded with the peptide mixture. The cartridge was then washed by an additional 3 ml 0.1 TFA%, and the peptides were eluted with 0.1% TFA in 50% acetonitrile in (1.5 ml). The eluted MHC peptides were reduced to near dryness and then reconstituted at 20 µL 0.1% TFA/water. Half of the peptide mixture, corresponding to approximately 3.5-4 x10 8 cell equivalents, was injected for LC-MS/MS analysis.
Analysis by mass spectrometry
For LC-MS/MS analysis, the MHC peptide mixture was separated on the Dionex U3000 capillary/nano-HPLC system (Dionex, Sunnyvale, California) that is directly interfaced with the Thermo-Fisher LTQ-Obritrap mass spectrometer (Thermo Fisher, San Jose, California). Prior to the analysis by tandem LC-MS/MS, the complex mixture was passed through a 10 kD filter to separate the peptides bound to the MHC II complex from other higher molecular weight peptides and proteins that might be present in the mixture eluted from the Ab column. The analytical column was a home-made fused silica capillary column (75 µm ID, 100 mm length; Upchurch, Oak Harbor, Washington) packed with C-18 resin (300 A, 5 mm, Varian, Palo Alto, California). To optimize the separation of peptides bound to the MHC II complex, the mixture was run on capillary/nano HPLC system with a shallow gradient of an aqueous mobile phase A (0.1% formic acid in water) and organic mobile phase B (0.1% formic acid in 100% acetonitrile) in 180 min with a flow rate of 250 nL/min under the following conditions: 0 % B to 55% B formed in 120 9 min, followed by 25 min gradient from 55% to 80% solvent B. Solvent B was maintained at 80% for another 10 min and then decreased to 0% in 10 min. Another 15 min interval was used for equilibration, loading and washing. The HPLC system was interfaced with the Thermo-Fisher LTQ Orbitrap XL mass spectrometer. The LTQ-Orbitrap mass spectrometer was operated in the data-dependent acquisition mode using the Xcalibur 2.0.7 software. The experiment consisted of a single MS full-scan in the Orbitrap (620-1200 m/z, 30,000 resolution) followed by 6 data-dependent MS/MS scans in the ion trap at 35% normalized collision energy. The most intense 6 masses from each full mass spectrum with doubly and triply charge states were selected for fragmentation by collision-induced dissociation in the linear ion-trap. The dynamic exclusion parameters were as follows: Repeat count = 1; Repeat Duration = 30 second; Exclusion list = 100;
and Exclusion time = 90 second.
Database search
The MS/MS spectra from each LC-MS/MS run were converted from the .RAW file format to .DTA files using the Bioworks 3.3.1 software. DTA files were analyzed using the MASCOT software search algorithm against IPI mouse database. The following search parameters were used in all MASCOT searches: the digestion enzyme was set as none and methionine oxidation as the variable modification. The maximum error tolerance for MS scans was 10 ppm for MS and 1.0 Da for MS/MS respectively. Peptide were identified by comparing the found sequences with the sequences deposited in the International Protein Index mouse (IPI) database. Only peptides with Mascot Score more than 20 and mass deviation less than 5 ppm were considered. Decoy database searches 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 using the MASCOT software yielded an estimated FDR of less than 10 using the above mentioned settings. Therefore, only peptides that could be confirmed by other search engines, SEQUEST (ThermoFinningan) and X!tandem (www.thegpm.org), were accepted. For peptides with Mascot scores 20-30 their MS/MS spectra were inspected manually to confirm that the major fragmented ions matched the identified peptide sequences. The unambiguous confirmation of the sequences of a subset of identified peptides was obtained by comparing the MS/MS spectra of eluted natural peptides with the MS/MS spectra obtained from the corresponding synthetic isotopically labeled counterparts (Table 1 , Fig.2 A-D) .
Prediction of peptide MHC II binding motifs
All source proteins were analyzed using the SYFPEITHI database (Table 1S) . 
Synthesis of isotopically labeled peptides
Functional profile analysis
The functional networks analyses were executed using Ingenuity Pathways Analysis (Ingenuity® Systems, www.ingenuity.com) software that enables the exploration of molecular interaction networks of source protein data sets. 14 confirmed by SEQUEST and X!tandem search engines. This software search, though, may have excluded additional peptide sequences that were present at levels below the detection limits set by the instrument for an automatic search and sequencing 51 . As shown in Tables 2-5 , the majority of detected peptides were 15-25 amino acids long, and several were clustered in nested sets consisting of 3-10 sequences, in agreement with published reports for B cells, macrophages, and B cell-derived cell lines 13, 14, [19] [20] [21] . A considerable number of single peptide sequences were also detected 52, 53 and they originated from different cellular compartments.
To confirm peptide identity and to perform further quantitation analysis (next section), a subset of identified peptides were synthesized as isotopically labeled peptides (Table 1) .
LC-MS/MS analysis was performed on the synthetic peptides, and obtained fragmentation spectra were compared with the corresponding spectra of the naturally presented MHC II peptides eluted from DCs and B cells. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 15 a total of around 80 proteins from membrane, extracellular, intracellular and nuclear compartments (Tables 2-5 and Fig. 3A ). The rate of detection of peptides listed in Tables   2-5 was 100 % in 7 biological replicates of DCs and 4 of B cells. As seen from Tables 2-5 and Fig. 3B , a significant number of class II-bound peptide sequences were shared by DCs and B cells and were derived from similar cellular compartments. We identified more peptides in DCs than in B cells, but the number of source proteins was quite comparable (Fig. 3B ). Forty-nine MHC class II-bound peptide sequences originating from 29 proteins were shared by DCs and B cells.
In previous reports that analyzed established cell lines 13 , the majority of the identified peptides were derived from membrane or secreted proteins such as MHC class II, invariant chain, beta globin, LDL receptor, apoliproproteins B and E. Importantly, here we showed that more than 50% of the endogenous MHC II peptides from mouse splenic H2bb, splicing factor 3B) ( Table 2 -5) . Peptides that originate from exogenous sources are present at high amount in the extracellular space, such as serum albumin or transferring (Table 5 ). These results indicate that the repertoire displayed on DCs as well as B cells is large, overlapping and derived from all cellular compartments (Fig. 3A ). Proteomic analysis of mouse DC subsets 54 reflected an exclusive expression of pattern recognition pathways. In three previous proteomic studies [55] [56] [57] (Table 5 and Table 1S ). For actin,
each with a different predicted binding motif and binding scores of 7, 10 and 20, respectively were identified (Table 3 and Table 1S ). Two binding motifs were found in 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 the three peptides derived from the Fanconi anemia complementation B protein (Table 4 and To evaluate the absolute abundance of MHC II peptides originating from different cellular compartments in DCs and B cells we performed a quantitation of selected peptides previously identified after LC-MS/MS analysis in these cell types. Our approach for peptides quantitation involved the use of isotopically labeled peptides as internal standards to quantify its natural endogenous counterpart 38 . We selected as quantitative targets 7 peptides derived from different cell compartments that were consistently detected in DCs (n=7) and B cells (n=4) ( Tables 2-5 ). First, we synthesized heavy isotope-labeled peptides corresponding to the endogenous counterparts introducing a single amino acid that was isotopically labeled with 13 C, 15 N (Table 1) . We added them as internal standards in the peptide mixture just prior to the LC-MS run ( Fig. 1 and Table 6 ).
Samples were analyzed by LC-MS and peak intensities of the unlabeled and the isotopically labeled pairs were compared. Fig. 4 shows, as an example, MS traces of the APO E peptides pair measured in the DCs sample ( Fig. 4B ) and of the SLAM 7 peptides pair measured in the B cells sample (Fig. 4A) . Results summarized in Table 6 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 19 them.
Quantitation of one of the peptides originating from the H-2 class II alpha chain showed that it was presented on the MHC II molecules in both DCs and B cells at similar levels of 1.18x10 5 copies per cell (Table 6 ). This peptide was unusually abundant in our studies.
Quantitation of another peptide originating from a membrane protein, Cap1 adenylyl cyclase-associated protein 1, showed that it was presented on the MHC II molecules in DCs and B cells at similar levels as most of the other selected peptides originating from proteins found in extracellular, lysosomal and cytosolic cellular compartments respectively i.e. about 133±18 copies per cell vs 299±30 copies per cell for Apolipoprotein E; 280±69 copies per cell for cathepsin Z and 273±13 copies per cell for Talin-1, respectively. But the peptide originating from the membrane protein SLAM family member 7 was present in both DCs and B cells at a very low level of 13±6 copies per cell (Table 6 ).
As shown in Table 6 , our approach resulted in the detection from a single experiment of a wide range of peptide concentrations starting from about 2.55 fmol/µL to 11.18 pmol/µL of sample or about 4000 fold difference in concentrations. Thus, in a single experiment, both excellent sensitivity and wide dynamic range were achieved. It should be noted that the concentration of detected peptides calculated in this way represents an underestimation of the actual concentration of these peptides bound to the MHC II complex in the DCs and B cells, respectively, because we added the isotopically labeled peptides in the sample aliquot prior to the LC-MS run and after the peptides were immunoprecipated and purified through 10 kD filter and C-18 column where some loss of peptides takes place 38 .
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Quantitative results summarized in Table 6, although 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 21 responsible for intracellular protein degradation (Fig. 1S) . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 22
The cell signaling and interaction network in B cells was characterized by a different set of proteins from the ones listed for DCs. They were the ANXA1 member of the annexin family that mediates anti-inflammatory responses, ALK, anaplastic lymphoma kinase that has a role in vascular development, BCAR3 that promotes cell migration, CAP1, adenyl cyclase associated protein 1 that regulates developmental and morphological processes, ILK, integrin like protein kinase that mediates cell architecture, ITGAX, integrin alpha X involved in cell-cell interactions during inflammation, MOV10L1 which is a RNA helicase involved in cell cycle progression, VCAN which has a role in cell adhesion, and TLX1, T-cell leukemia homebox protein required for normal development of the spleen.
Proteins that grouped in the cell morphology network were cytochrome C oxidase subunit, COX6A1, that mediates mitochondrial electron transport, protein diaphanous homolog 1, DIAPH1, required for the assembly of F-actin structures; 2'-5' oligonucleotide synthesase 1B, OAS1b, which controls cell growth and differentiation and Ras-related protein Rab-B which mediates retrograde membrane traffic. Several transcriptional factors also were grouped in this network. These were helicase-like transcription factor, HLTF, which maintains genome stability through posttranscriptional repair of damaged DNA, the splicing factor SFPQ, which regulates posttranscriptional processes and the forkhead box protein D1, FOXD1. Only few proteins that were grouped in the cell to cell signaling and interaction network were shared between DCs and B cells. These were apolipoprotein E (APOE) and fibronectin 1 (FN1).
Discussion
The actual sequences of peptides that are naturally presented on MHC II molecules cannot be easily predicted, in fact such peptides have been demonstrated to display a high analysis compared to what is described in other reports for cell lines 13, 14 . Also, we used smaller numbers of mice to obtain the DCs compared to the numbers used in other studies, which have concentrated on DCs generated from bone marrow cultures rather than DCs taken directly from mice 54, 66 . Flt3L treatment expanded the number of murine These quantitative data were robust enough to overcome the dynamic range of copy numbers that spanned several orders of magnitude. Our quantitation results (Table 6) indicate that there is a large difference in the in vivo presentation of different endogenous MHC II peptides both in DCs and B cells, with about 4000 fold differences in amounts between the most abundant H-2 class II alpha chain peptide and the least abundant peptide originating from the lymphocyte antigen SLAM family member 7. This wide difference in presentation of endogenous MHC II peptides derived from different proteins 59 , while Kumar and Ranganathan reported that the majority of the analyzed 6900 human proteins are localized in the nucleus (38%) and plasma membrane (23%) 60 . The general conclusion of all of these studies is that the intracellular distribution of mammalian proteins is not 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 26 marrow DCs and thymocytes 66 . It was found that cell specific source proteins for 417 peptides identified in DCs and 187 peptides from thymocytes were grouped in networks that characterize their distinct functions in the immune system. Myeloid differentiation, proteosome function and toll-like receptor signaling were the main networks for bone marrow DCs treated with LPS as a maturation stimulus, while in thymocytes, the source proteins were grouped into networks that regulate tight junctions, purine metabolism and the cell cycle.
Comparison of the source proteins for the MHC I peptides identified in bone marrow 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 29 cell sample. B) MS profile of the Apo E peptides pair identified in the MHC II peptide mixture eluted from one representative DC sample. Isotopic patterns of the ions were consistent with the predicted patterns based on the isotopic ratios. Mass shifts of the isotopically labeled peptides are consistent with the predicted values (see Table 1 ). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 30 peptides with a MASCOT score greater than 20 and mass accuracy better than 5 ppm were included. Sequences highlighted in bold letters were selected for further quantitation analysis (see Table 1 ). Peptides and their source proteins were identified as described in Legend to Table 2 . Table 4 . MHC II binding peptides derived from endo/lysosomal and nuclear proteins of DCs and B cells. Peptides and their source proteins were identified as described in Legend to Table 2 . Table 5 . MHC II binding peptides derived from extracellular proteins of DCs and B cells.
Peptides and their source proteins were identified as described in Legend to Table 2 . Table 6 . Quantitation experiments of selected MHC II associated peptides eluted from
DCs and B cells. Peptides were first identified from DCs and B cells by LC-MS/MS
analysis (see Tables 2-5) . Peptide abundance was then measured by LC-MS using stable isotope labeled peptides as internal standards (see Table 1 and Materials and Methods).
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